| |
 |
Emerging Hsp90 Inhibitors: From Discovery to Clinic
 |
| |
|
pp.1-8 (8) Authors: G. Chiosis, A. Rodina, K. Moulick |
| |
|
|
| |
|
Peptide Toxins Directed at the Matrix Dissolution Systems of Cancer Cells
|
| |
|
pp.1-14 (14) Authors: T. I. Samoylova, N. E. Morrison, L. P. Globa, N. R. Cox, Arthur E. Frankel, Thomas H. Bugge, Shihui Liu, Daniel A. Vallera, Stephen H. Leppla |
| |
|
|
| |
|
Gold Coordination Complexes as Anticancer Agents
|
| |
|
pp.19-32 (14) Authors: Irena Kostova, Bentham Science Publishers |
| |
|
|
| |
|
Marine Peptides and Related Compounds in Clinical Trial+
|
| |
|
pp.33-40 (8) Authors: Diwan S. Rawat, Mukesh C. Joshi, Penny Joshi, Himanshu Atheaya |
| |
|
|
| |
|
Understanding Apoptosis in Terms of QSAR
|
| |
|
pp.41-52 (12) Author: Rajeshwar P. Verma |
| |
|
|
| |
|
Vitamin D Analogs as Anti-Carcinogenic Agents
|
| |
|
pp.53-71 (19) Authors: E. S. Agoston, M. A. Hatcher, T. W. Kensler, G. H. Posner |
| |
|
|
